Procept Biorobotics CORP Form 4 insider transactions

Hisham Shiblaq, EVP and Chief Commercial Officer of Procept BioRobotics, exercised stock options and sold shares on June 10, 2024, according to a Form 4 filing.

Director Antal Rohit Desai reports acquisition of common stock and stock options in Procept BioRobotics Corp.

Director Taylor C. Harris reports acquisition and disposal of Procept BioRobotics Corp (PRCT) common stock and stock options.

Director Amy M. Dodrill reports acquiring 1,376 shares of common stock and 2,526 stock options in Procept BioRobotics Corp on June 4, 2024.

Director Mary Garrett reported the acquisition of stock options and vesting of restricted stock units (RSUs) in Procept BioRobotics Corp.

Director Thomas Krummel reports acquisition of restricted stock units and stock options in Procept BioRobotics Corp.

Director Larry Wood reports acquisition of 1,376 shares of common stock and options to purchase 2,526 shares of common stock in Procept BioRobotics Corp.

Director Frederic Moll reports acquisition of restricted stock units and stock options in Procept BioRobotics Corp.

Elisabeth Sandoval, a director at PROCEPT BioRobotics Corp, reports the acquisition of restricted stock units and stock options.

Director Antal Rohit Desai reports pro rata distributions of Procept BioRobotics Corp shares from investment partnerships and trusts, with no consideration involved.

R Kent McGaughy Jr., a director and 10% owner of PROCEPT BioRobotics Corp, reports a pro rata distribution of shares from White Tailed Ptarmigan, LP, resulting in changes in beneficial ownership.

Director Antal Rohit Desai reports a pro rata distribution of shares from White Tailed Ptarmigan, LP and adjustments to beneficial ownership in Procept BioRobotics Corp.

Director Thomas Krummel sold 20,000 shares of Procept BioRobotics Corp (PRCT) on May 1, 2024, at a price of $60 per share, according to a Form 4 filing.

Alaleh Nouri, EVP, CLO, and Corporate Secretary of Procept BioRobotics, reports exercising stock options and selling shares on May 3, 2024.

Director Larry Wood reports the acquisition of restricted stock units and stock options in Procept BioRobotics Corp.

Reza Zadno, CEO of Procept BioRobotics, files an amended Form 4 to correct clerical errors in the number of shares related to stock options and restricted stock units (RSUs) granted on March 6, 2024.

Kevin Waters, CFO of Procept BioRobotics, files an amended SEC Form 4 to correct clerical errors in the number of shares and options granted on March 6, 2024.

Alaleh Nouri, EVP, CLO, CORP. SEC. of Procept BioRobotics Corp, sold 441 shares of common stock on March 18, 2024, to cover tax withholding obligations related to vesting Restricted Stock Units.

Kevin Waters, EVP and CFO of Procept BioRobotics Corp, sold 1,024 shares of common stock on March 18, 2024, to cover tax withholding obligations related to vesting Restricted Stock Units.

CEO Reza Zadno sold 5,391 shares of PROCEPT BioRobotics Corp to cover tax obligations related to vesting Restricted Stock Units.

Hisham Shiblaq, EVP and Chief Commercial Officer of Procept BioRobotics, sold 244 shares of common stock on March 18, 2024, to cover tax withholding obligations related to vesting Restricted Stock Units.

Kevin Waters, EVP and CFO of Procept BioRobotics, reports exercising stock options and subsequent changes in beneficial ownership.

Alaleh Nouri, EVP, CLO, and Corporate Secretary of Procept BioRobotics, reports acquisition and disposal of common stock and stock options.

Kevin Waters, EVP and CFO of Procept BioRobotics, reports acquisition and disposal of common stock and stock options related to restricted stock units.

CEO Reza Zadno reports acquisition and disposal of PROCEPT BioRobotics Corp stock and stock options related to vesting RSUs and tax obligations.

Hisham Shiblaq, EVP and Chief Commercial Officer of Procept BioRobotics, reports the acquisition and disposal of common stock and stock options.

Director Thomas Krummel sold shares of Procept BioRobotics Corp (PRCT) on March 4, 2024, under a pre-arranged Rule 10b5-1 trading plan.